vorinostat has been researched along with Papillomavirus Infections in 3 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Papillomavirus Infections: Neoplasms of the skin and mucous membranes caused by papillomaviruses. They are usually benign but some have a high risk for malignant progression.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banerjee, NS | 1 |
Moore, DW | 1 |
Broker, TR | 1 |
Chow, LT | 1 |
Citro, S | 1 |
Bellini, A | 1 |
Miccolo, C | 1 |
Ghiani, L | 1 |
Carey, TE | 1 |
Chiocca, S | 1 |
Yuan, H | 1 |
Myers, S | 1 |
Wang, J | 1 |
Zhou, D | 1 |
Woo, JA | 1 |
Kallakury, B | 1 |
Ju, A | 1 |
Bazylewicz, M | 1 |
Carter, YM | 1 |
Albanese, C | 1 |
Grant, N | 1 |
Shad, A | 1 |
Dritschilo, A | 1 |
Liu, X | 1 |
Schlegel, R | 1 |
3 other studies available for vorinostat and Papillomavirus Infections
Article | Year |
---|---|
Vorinostat, a pan-HDAC inhibitor, abrogates productive HPV-18 DNA amplification.
Topics: Apoptosis; Bcl-2-Like Protein 11; Cells, Cultured; DNA Repair; DNA Replication; DNA-Binding Proteins | 2018 |
Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for ΔNp63α.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Gefitinib; Histone Deacetylase Inhib | 2019 |
Use of reprogrammed cells to identify therapy for respiratory papillomatosis.
Topics: Antineoplastic Agents; Cells, Cultured; DNA, Viral; Gene Expression; Genome, Viral; Human papillomav | 2012 |